Bailey Jeffrey Allen
SEC insider (Form 3/4/5 filer). CIK 0001500210. Director at Aurinia Pharmaceuticals Inc. (AUPH). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in EDMONTON.
Companies Bailey Jeffrey Allen has filed insider reports for
- Aurinia Pharmaceuticals Inc. (AUPH): Director
Bailey Jeffrey Allen
CIK: 0001500210
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aurinia Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 4, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirectDirector Stock Option (right to buy)
23.9K shares- - Nov 21, 2025AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect2.7K shares at avg. $15.68$43K - May 16, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirectDirector Stock Option (right to buy)
37.5K shares- - Nov 21, 2024AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect12.1K shares- - Nov 11, 2024AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect4.6K shares at avg. $8.43$38K - Nov 8, 2024AUPH
Aurinia Pharmaceuticals Inc.
ExerciseDirect17.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Award Director Stock Option (right to buy) | 23,931 | - | - | Direct |
| Nov 21, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 2,716 | $15.68 | $42,587 | Direct |
| May 16, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award Director Stock Option (right to buy) | 37,485 | - | - | Direct |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Award | 12,135 | - | $0 | Direct |
| Nov 11, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 4,557 | $8.43 | $38,416 | Direct |
| Nov 8, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Exercise | 17,913 | - | $0 | Direct |
1-6 of 6 transactions